1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. ARGEN X SE - ADR
Argen X SE - ADR XNAS: ARGX

Argen X SE (ADR) Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized mya...

Read More
728.09 -14.70 (-1.98%)
42.75% Gain from 52W Low
359.5K
XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Argen X SE (ADR) is on 20 Mar 2026 for the purpose of argenx SE Annual Report for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Mid Valuation
32.8 / 100
Momentum Score
Technically Neutral
44.6 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
1,021
1Yr Price target upside is 40%
22 analysts

8

S

14

W

1

O

4

T

SWOT Analysis

Argen X SE (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..